Search research articles
Contact Us
Filters
Showing results (1-10 of 30) with videos related to
Page
of 3
Sort By:
CMAJ Open
|
April 7, 2018
Evaluation of the cost-effectiveness of evolocumab in the FOURIER study: a Canadian analysis
Todd C Lee, Mohammed Kaouache, Steven A Grover
The Canadian Journal of Cardiology
|
February 28, 2021
Gambling With Cardiovascular Disease Risk Models: How to Choose and How to Use
Steven A Grover, Hiba Jekki, Mohammed Kaouache, et al.
The Canadian Journal of Cardiology
|
May 10, 2007
Preventing cardiovascular disease among Canadians: what are the potential benefits of treating hypertension or dyslipidemia?
Steven A Grover, Louis Coupal, Mohammed Kaouache, et al.
Archives of Internal Medicine
|
October 28, 2009
Evaluating the incremental benefits of raising high-density lipoprotein cholesterol levels during lipid therapy after adjustment for the reductions in other blood lipid levels
Steven A Grover, Mohammed Kaouache, Lawrence Joseph, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
April 16, 2025
Diagnostic Utility of Biomarkers in Anaphylaxis: A Systematic Review and Meta-Analysis
Roy Khalaf, Connor Prosty, William Davalan, et al.
Circulation
|
November 25, 2015
Stroke in Adults With Congenital Heart Disease: Incidence, Cumulative Risk, and Predictors
Jonas Lanz, James M Brophy, Judith Therrien, et al.
Circulation
|
June 20, 2014
Lifetime prevalence of congenital heart disease in the general population from 2000 to 2010
Ariane J Marelli, Raluca Ionescu-Ittu, Andrew S Mackie, et al.
Journal of General Internal Medicine
|
October 22, 2008
Discussing coronary risk with patients to improve blood pressure treatment: secondary results from the CHECK-UP study
Steven A Grover, Ilka Lowensteyn, Lawrence Joseph, et al.
Archives of Internal Medicine
|
November 28, 2007
Patient knowledge of coronary risk profile improves the effectiveness of dyslipidemia therapy: the CHECK-UP study: a randomized controlled trial
Steven A Grover, Ilka Lowensteyn, Lawrence Joseph, et al.
Pediatrics
|
January 3, 2025
Optimizing Management of Febrile Young Infants Without Serum Procalcitonin
Brett Burstein, Caroline Wolek, Cassandra Poirier, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 30) with videos related to
Sort By:
Page
of 3
CMAJ Open
|
April 7, 2018
Evaluation of the cost-effectiveness of evolocumab in the FOURIER study: a Canadian analysis
Todd C Lee, Mohammed Kaouache, Steven A Grover
The Canadian Journal of Cardiology
|
February 28, 2021
Gambling With Cardiovascular Disease Risk Models: How to Choose and How to Use
Steven A Grover, Hiba Jekki, Mohammed Kaouache, et al.
The Canadian Journal of Cardiology
|
May 10, 2007
Preventing cardiovascular disease among Canadians: what are the potential benefits of treating hypertension or dyslipidemia?
Steven A Grover, Louis Coupal, Mohammed Kaouache, et al.
Archives of Internal Medicine
|
October 28, 2009
Evaluating the incremental benefits of raising high-density lipoprotein cholesterol levels during lipid therapy after adjustment for the reductions in other blood lipid levels
Steven A Grover, Mohammed Kaouache, Lawrence Joseph, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
April 16, 2025
Diagnostic Utility of Biomarkers in Anaphylaxis: A Systematic Review and Meta-Analysis
Roy Khalaf, Connor Prosty, William Davalan, et al.
Circulation
|
November 25, 2015
Stroke in Adults With Congenital Heart Disease: Incidence, Cumulative Risk, and Predictors
Jonas Lanz, James M Brophy, Judith Therrien, et al.
Circulation
|
June 20, 2014
Lifetime prevalence of congenital heart disease in the general population from 2000 to 2010
Ariane J Marelli, Raluca Ionescu-Ittu, Andrew S Mackie, et al.
Journal of General Internal Medicine
|
October 22, 2008
Discussing coronary risk with patients to improve blood pressure treatment: secondary results from the CHECK-UP study
Steven A Grover, Ilka Lowensteyn, Lawrence Joseph, et al.
Archives of Internal Medicine
|
November 28, 2007
Patient knowledge of coronary risk profile improves the effectiveness of dyslipidemia therapy: the CHECK-UP study: a randomized controlled trial
Steven A Grover, Ilka Lowensteyn, Lawrence Joseph, et al.
Pediatrics
|
January 3, 2025
Optimizing Management of Febrile Young Infants Without Serum Procalcitonin
Brett Burstein, Caroline Wolek, Cassandra Poirier, et al.
Page
of 3